Method and kit for chromatographic separation of hemoglobin A.sub.1c

• US 4,389,491 A
• Filed: 04/26/1982
• Issued: 06/21/1983
• Est. Priority Date: 04/26/1982
• Status: Expired due to Term

• Current Assignee: Bio-Rad Laboratories Incorporated
• Original Assignee: Bio-Rad Laboratories Incorporated
• Inventors: Hanamoto, Mark S., Tanaka, Steve K.
• Primary Examiner(s): Marantz, Sidney
• Application Number:
  US06/371,844
• Time in Patent Office: 421 Days
• Field of Search: 436/67, 422/61, 210/656
• US Class Current: 426/72
• CPC Class Codes: G01N 33/723 Glycosylated haemoglobin

Abstract

An ion exchange method and kit for the separation of hemoglobin A_1c from other hemoglobin components in a sample of human blood. The sample is lysed, then used to impregnate a weak cation exchanger. Two buffer solutions are then passed through the column in succession, the first having an alkali metal ion concentration of from about 0.02M to about 0.05M and the second having an alkali metal ion concentration of from about 0.06M to about 0.11M. The second eluate contains substantially all of the hemoglobin A_1c and substantially none of the other hemoglobin components in the original sample. Analysis of the second eluate thus provides a reliable indication of the long-term glucose level in the blood of a patient, and hence the patient'"'"'s ability to regulate the quantity of glucose ingested. The hemolysate with the Schiff base precursor is introduced directly to the chromatographic column.

Claims

1. A method for the separation of hemoglobin A_1c from other glycosylated and nonglycosylated hemoglobins and the Schiff base precursor to hemoglobin A_1c in a sample of human blood which comprises:

(a) lysing the red blood cells contained in said sample to form a hemolysate containing said hemoglobin A_1c, said glycosylated and nonglycosylated hemoglobins, and said Schiff base precursor,

(b) impregnating a weak cation exchanger with said hemolysate,

(c) passing through said exchanger a first buffer solution with ions of an alkali metal dissolved therein at a concentration of from about 0.02 M to about 0.05 M to dissociate said Schiff base precursor into glucose and hemoglobin A and to preferentially elute said glucose and said other glycosylated hemoglobins over said hemoglobin A, said hemoglobin A_1c and said other nonglycosylated hemoglobins,

(d) passing through said exchanger a second buffer solution containing ions of an alkali metal dissolved therein at a concentration of from about 0.06 M to about 0.11 M to preferentially elute said hemoglobin A_1c over said hemoglobin A and said other nonglycosylated hemoglobins, and

(e) recovering the eluate from step (d).

2. A method according to claim 1, in which said cations on said exchanger are alkali metal ions, and said alkali metal ions in said first and second buffer solution are identical in type to each other and to those on said exchanger.

3. A method according to claim 2, in which said alkali metal ions on said exchanger and in said first and second buffer solutions are identical and have an atomic weight equal to or less than that of potassium.

4. A method according to claim 2, in which said alkali metal ions on said exchanger and in said first and second buffer solutions are identical and are selected from the group consisting of sodium and potassium.

5. A method according to claim 2, in which said alkali metal ions on said exchanger and in said first and second buffer solutions are sodium ions.

6. A method according to claim 1, in which said exchanger is a copolymer of methacrylic acid and divinylbenzene and from about 30% to about 50% of the active sites on said exchanger are occupied by ions of an alkali metal.

7. A method according to claim 1, in which the concentration of alkali metal ions in said first buffer solution is from about 0.03 M to about 0.04 M.

8. A method according to claim 1, in which the concentration of alkali metal ions in said second buffer solution is from about 0.07 M to about 0.09 M.

9. A method according to claim 1, in which said exchanger is a copolymer of methacrylic acid and divinylbenzene and from about 30% to about 50% of the active sites on said exchanger are occupied by alkali metal ions, the concentration of alkali metal ions in said first buffer solution is from about 0.03 M to about 0.04 M, the concentration of alkali metal ions in said second buffer solution is from about 0.07 M to about 0.09 M and all of said alkali metal ions are sodium ions.

10. A method according to any of claims 5-9 in which said first and second buffer solutions are phosphate buffers.

11. A method according to any of claims 5-9 in which the pH of said first buffer solution and the pH of said second buffer solution are each within the range of about 6.3 to about 7.3.

12. A method according to claim 1, in which said resin is a polymer of methacrylic acid with a particle size within the range of about 100 to about 400 mesh.

13. A method according to claim 1, in which said resin is a copolymer of methacrylic acid and divinylbenzene with a particle size within the range of about 200 to about 400 mesh.

14. A method according to claim 1, in which steps (c) and (d) are performed at a temperature of from about 14°

C. to about 35°

C.

15. A method according to claim 1, in which steps (c) and (d) are performed at a temperature of from about 17°

C. to about 30°

C.

16. A method according to claim 1, in which all of said alkali metal ions are sodium ions, said first and second buffer solutions are phosphate buffers, each with a pH within the range of about 6.3 to about 7.3, said exchanger is a copolymer of methacrylic acid and divinylbenzene on which about 35% to about 45% to whose active sites are occupied by said sodium ions, the concentration of said sodium ions in said first buffer solution is from about 0.03 M to about 0.04 M, the concentration of said sodium ions in said second buffer solution is from about 0.07 M to about 0.09 M and steps (c) and (d) are performed at a temperature of from about 20°

C. to about 28°

C.

17. A method according to claim 1, in which step (a) is accomplished by adding said sample to an aqueous detergent solution and incubating the resulting mixture at approximately room temperature for at least about ten minutes.

18. A method according to claim 1, in which an effective amount of a dihydroxyboryl compound is present in at least one member selected from the group consisting of said hemolysate prior to step (b), said first buffer solution prior to step (c), and said second buffer solution prior to step (d).

19. A method according to claim 1, in which step (a) is achieved by combining said sample with an aqueous detergent solution, and a dihydroxyboryl compound is added to said detergent solution prior to step (a), to said first buffer solution prior to step (c), or to said second buffer solution prior to step (d), at a concentration of from about 0.01 M to about 1.00 M.

20. A method according to claim 1, in which step (a) is achieved by combining said sample with an aqueous detergent solution, and a dihydroxyboryl compound is added to said detergent solution prior to step (a) at a concentration of from about 0.1 M to about 1.0 M.

21. A method according to claim 1, in which step (a) is achieved by combining said sample with an aqueous detergent solution, and a dihydroxyboryl compound is added to said detergent solution prior to step (a) at a concentration of from about 0.1 M to about 1.0 M, and the pH of said hemolysate is maintained at a value ranging from about 4.5 to about 6.5.

22. A method according to claim 1, in which step (a) is achieved by combining said sample with an aqueous detergent solution, and a dihydroxyboryl compound is added to said detergent solution prior to step (a) at a concentration of from about 0.1 M to about 1.0 M, and the pH of said hemolysate is maintained at about 5.5.

23. A method according to claim 1, in which a dihydroxyboryl compound is added to said first buffer solution prior to step (c) at a concentration of from about 0.01 M to about 0.10 M.

24. A method according to claim 1, in which step (a) is achieved by combining said sample with an aqueous detergent solution, and a dihydroxyboryl compound is added to said detergent solution prior to step (a) at a concentration of from about 0.1 M to about 1.0 M, and to said first buffer solution prior to step (c) at a concentration of from about 0.01 M to about 0.10 M.

25. A method according to claim 1, in which step (a) is achieved by combining said sample with an aqueous detergent solution, and a dihydroxyboryl compound is added to said detergent solution prior to step (a) at a concentration of from about 0.1 M to about 1.0 M, and the pH of said hemolysate is maintained at a value ranging from about 4.5 to about 6.5, and further dihydroxyboryl compound is added to said first buffer solution at a concentration of from about 0.01 M to about 0.10 M.

26. A method according to claim 1, in which step (a) is achieved by combining said sample with an aqueous detergent solution, and a dihydroxyboryl compound is added to said detergent solution prior to step (b) at a concentration of from about 0.1 M to about 1.0 M, and the pH of said hemolysate is maintained at about 5.5, and further dihydroxyboryl compound is added to said first buffer solution at a concentration of from about 0.01 M to about 0.10 M.

27. A method according to any of claims 18-26 in which said dihydroxyboryl compound is selected from the group consisting of boric acid and lower alkyl boronic acids.

28. A method according to any of claims 18-26 in which said dihydroxyboryl compound is boric acid.

29. A method for determining the level of hemoglobin A_1c in a sample of human blood containing other glycosylated hemoglobins and the Schiff base precursor to hemoglobin A_1c which comprises:

(a) lysing the red blood cells contained in said sample to form a hemolysate containing said hemoglobin A_1c, said glycosylated and nonglycosylated hemoglobins, and said Schiff base precursor,

(b) impregnating a cation exchanger consisting essentially of a copolymer of methacrylic acid and divinylbenzene about 30% to about 50% of whose active sites are occupied by ions of an alkali metal, the remainder occupied by hydrogen ions, with said hemolysate,

(c) passing through said exchanger a first buffer solution with ions of an alkali metal dissolved therein at a concentration of from about 0.02 M to about 0.05 M to dissociate said Schiff base precursor into glucose and hemoglobin A and to preferentially elute said glucose and said other glycosylated hemoglobins over said hemoglobin A, said hemoglobin A_1c and said other nonglycosylated hemoglobins,

(d) passing through said exchanger a second buffer solution containing ions of an alkali metal dissolved therein at a concentration of from about 0.06 M to about 0.11 M to preferentially elute said hemoglobin A_1c over said hemoglobin A and said other nonglycosylated hemoglobins, and

(e) analyzing the eluate from step (d) for hemoglobin A_1c.

30. A method for determining the level of hemoglobin A_1c in a sample of human blood containing other glycosylated hemoglobins and the Schiff base precursor to hemoglobin A_1c which comprises:

(a) lysing the red blood cells contained in said sample to form a hemolysate containing said hemoglobin A_1c, said glycosylated and nonglycosylated hemoglobins, and said Schiff base precursor, by adding said sample to an aqueous solution of a detergent consisting essentially of a polyoxyethylene ether surfactant and further containing from about 0.1 M to about 1.0 M boric acid adjusted to pH of about 5.5,

(b) impregnating a cation exchanger with said hemolysate, said cation exchanger consisting essentially of a copolymer of methacrylic acid and divinylbenzene with a particle size within the range of about 100 to about 400 mesh and about 30% to about 50% of whose active sites are occupied by sodium ions, the remainder occupied by hydrogen ions,

(c) passing through said exchanger a first phosphate buffer solution with sodium ions dissolved therein at a concentration of from about 0.03 M to about 0.04 M and further containing from about 0.01 M to about 0.03 M boric acid, the pH of said buffer solution ranging from about 6.5 to about 7.0, to dissociate said Schiff base precursor into glucose and hemoglobin A and to preferentially elute said glucose and said other glycosylated hemoglobins over said hemoglobin A, said hemoglobin A_1c and said other nonglycosylated hemoglobins,

(d) passing through said exchanger a second phosphate buffer solution with sodium ions dissolved therein at a concentration of from about 0.07 M to about 0.09 M, the pH of said buffer solution ranging from about 6.5 to about 7.0, to preferentially elute said hemoglobin A_1c over said hemoglobin A and said other nonglycosylated hemoglobins, and

(e) analyzing the eluate from step (d) for hemoglobin A_1c.

31. A kit for use in an assay for determining the hemoglobin A_1c content in a sample of human blood without interference from other glycosylated or nonglycosylated hemoglobins or the Schiff base precursor to hemoglobin A_1c, said kit comprising:

(a) a weak cation exchanger,

(b) a first buffer solution with ions of an alkali metal dissolved therein at a concentration of from about 0.02 M to about 0.05 M, and

(c) a second buffer solution with ions of an alkali metal dissolved therein at a concentration of from about 0.06 M to about 0.11 M.

32. A kit according to claim 31, further comprising a hemolysis reagent comprising an aqueous detergent solution.

33. A kit according to claim 31, further comprising a hemolysis reagent comprising an aqueous detergent solution containing a dihydroxyboryl compound at a concentration of from about 0.1 M to about 1.0 M, and in which said first buffer solution further contains a dihydroxyboryl compound at a concentration of from about 0.01 M to about 0.10 M.